---
title: "LENSAR, Inc. (LNSR.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/LNSR.US.md"
symbol: "LNSR.US"
name: "LENSAR, Inc."
industry: "醫療器械"
---

# LENSAR, Inc. (LNSR.US)

| Item | Detail |
|------|--------|
| Industry | 醫療器械 |
| Location | 美股市場 |
| Website | [www.lensar.com](https://www.lensar.com) |

## Company Profile

LENSAR, Inc.是一家商業階段的醫療設備公司，專注于設計、開發和營銷激光系統，用于治療白內障以及管理已有的或手術引起的角膜散光。該公司提供 LENSAR 激光系統，結合了一系列專有技術，旨在通過提供成像、手術規劃、設計和精確度來幫助外科醫生獲得視覺效果。它還提供 ALLY 機器人白內障激光系統，這是一種緊湊型白內障治療系統，旨在讓外科醫生能夠在一個手術室內進行無菌的激光輔助白內障手術。LENSAR, Inc

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-20T04:30:12.000Z

**Overall: C (0.46)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 80 / 185 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 21.02% |  |
| Net Profit YoY | -209.86% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -5.25 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 135.93M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 59.14M |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 3251.75% | A |
| Profit Margin | -87.12% | E |
| Gross Margin | 42.16% | B |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 21.02% | A |
| Net Profit YoY | -209.86% | E |
| Total Assets YoY | 13.20% | B |
| Net Assets YoY | -133.19% | E |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -114.78% | D |
| OCF YoY | 21.02% | A |

#### Operating Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.89 | B |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 117.27% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - LENSAR, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "3251.75%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-87.12%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "42.16%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "21.02%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-209.86%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "13.20%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "-133.19%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-114.78%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "21.02%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "B",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.89",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "117.27%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 啟迪醫療 (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | 直覺外科 (US.ISRG) | A | B | C | A | B | B |
| 04 | 史賽克 (US.SYK) | A | B | C | C | B | B |
| 05 | 波士頓科學 (US.BSX) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -2.64 | 100/181 | - | - | - |
| PB | -5.25 | 156/181 | 34.53 | 33.73 | 32.71 |
| PS (TTM) | 2.30 | 55/181 | 2.89 | 2.55 | 2.41 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-11-11T05:00:00.000Z

Total Analysts: **2**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 2 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 11.69 |
| Highest Target | 15.00 |
| Lowest Target | 15.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/LNSR.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/LNSR.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/LNSR.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.